Key result
Among 965 patients undergoing cardiac device procedures, the most common complications were device-related infection (0.8%) and lead-related reintervention (0.6%), with a 1-month mortality of 0.1%.
Why the study?
The authors sought to evaluate various cardiac device treatments across clinical scenarios at their center and compare complication rates with current literature to revise clinical protocols.
Observational (n=965)
No
Cardiac implantable electronic device procedures demonstrate a low rate of major complications and a 1-month procedure-related mortality of 0.1% in a real-world single-center experience.
Objectives: In this study, we examined the various device treatments that we applied to patients in different scenarios in our clinic and compared the complication rates we encountered with the current literature.This study revised our usual protocols to avoid and treat possible events at an early stage. Materials and Methods:Between September 2016 and March 2022, 965 consecutive children and adult patients (66.2% men; 66.4±14.0years) who underwent 1018 cardiac device procedures at our center were analyzed retrospectively.The clinical and electrophysiological characteristics of the study group were evaluated. Results:The total number of device procedures performed in the electrophysiology laboratory was 1018, including 709 cardiac device implantations, 236 generator replacements, 59 lead revisions, and 14 lead extractions.In the pacemaker group, the study population was older and mostly female [306 patients (48.7% men); 71.1±15.0years], compared to the implantable cardioverter defibrillators and cardiac resynchronization therapy groups [254 patients (82.2% men); 62.1±13.2years and 149 patients (75.1% men); 60.1±9.6 years, respectively].Regarding procedure-related complications, the most common complications were device-related infection (8 patients, 0.8%) and lead-related reintervention (6 patients, 0.6%).Following in order: vascular complications included coronary sinus (6 patients, 0.6%), axillary vein dissection/perforation (3 patients, 0.3%), pneumothorax (4 patients, 0.4%), diaphragmatic stimulation requiring reintervention (2 patients, 0.2%), and cardiac perforation (1 patient, 0.1%) were other complications we encountered.No patient had a device-related hemothorax or brachial plexus injury.The procedure-related mortality rate following the index procedure during the first month was 0.1%.
No takes yet. Share an insight, caveat, or question.
Görmel et al. (2022) conducted an observational in Patients requiring cardiac implantable electronic devices (n=965). Cardiac device procedures was evaluated on Procedure-related complications and mortality. Among 965 patients undergoing cardiac device procedures, the most common complications were device-related infection (0.8%) and lead-related reintervention (0.6%), with a 1-month mortality of 0.1%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: